Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Seizures (Incl Subtypes)Brain Tumor
Interventions
DRUG

Magnesium Sulfate

"At the beginning of the neurosurgery, the subjects are going to receive one 4gr bolus in Sodium Chloride 100 mL, lasting 20 minutes, intravenously.~After that, a intravenously perfusion of Magnesium Sulfate 20 gr, in Sodium Chloride 1000 mL, lasting 24 hours, will be started."

OTHER

Sodium Chloride

"At the beginning of the neurosurgery, the subjects are going to receive a bolus of Sodium Chloride 100 mL, lasting 20 minutes, intravenously.~After that, a intravenously perfusion of Sodium Chloride 1000 mL, lasting 24 hours, will be started."

Trial Locations (1)

08036

Hospital Clinic of Barcelona, Barcelona

All Listed Sponsors
lead

Sara Varea

OTHER

NCT01601314 - Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients | Biotech Hunter | Biotech Hunter